Cargando…

Differences in tumour necrosis factor productive ability among rodents.

Large differences in tumour necrosis factor (TNF) productive ability 05337257erved among various strains of mice. DDY, CD-1, ICR and DBA/2 mice could produce a high titre of TNF activity, whereas Balb/c, C3H/HeJms and A/J mice produced a low titre of TNF activity. Administration of 200 micrograms/mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haranaka, K., Satomi, N., Sakurai, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1984
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976898/ https://www.ncbi.nlm.nih.gov/pubmed/6386027

Ejemplares similares

Relationship of hypoxia to metastatic ability in rodent tumours
por: Jaeger, K De, et al.
Publicado: (2001)

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
por: MÃ¤nnel, D. N., et al.
Publicado: (1989)

Tumour-necrosis factor from the rabbit. II. Production by monocytes.
por: Matthews, N.
Publicado: (1978)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Tumour Necrosis Factor-α Production and Immune Cell Activation in Tuberculous Meningitis
por: Mastroianni, C. M., et al.
Publicado: (1994)

Sex differences in the ability of corticostriatal oscillations to predict rodent alcohol consumption
por: Henricks, Angela M., et al.
Publicado: (2019)

Cimetidine and therapy of rodent tumours.
por: Hannant, D., et al.
Publicado: (1982)

Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific
por: Pantelidis, Panos, et al.
Publicado: (2001)

Tumour necrosis factor in man: clinical and biological observations.
por: Selby, P., et al.
Publicado: (1987)

Carnitine and congeners as regulators of tumour necrosis factor
por: De Simone, Claudio, et al.
Publicado: (1993)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Inhibitory effect of esculentoside A on tumour necrosis factor α production by human monocytes
por: Wang, H-B., et al.
Publicado: (1996)

The distribution of porphyrins with different tumour localising ability among human plasma proteins.
por: Kongshaug, M., et al.
Publicado: (1989)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Relationship between tumour cell morphology, gap junctions and susceptibility to cytolysis by tumour necrosis factor.
por: Matthews, N., et al.
Publicado: (1989)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway
por: González-Alvaro, I, et al.
Publicado: (2008)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid.
por: Ching, L. M., et al.
Publicado: (1995)

Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours.
por: van de Weil, P. A., et al.
Publicado: (1990)

Tumour-necrosis factor from the rabbit. III. Relationship to interferons
por: Matthews, N.
Publicado: (1979)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

A nontoxic tumour necrosis factor induced by streptococcal lipoteichoic acids.
por: Usami, H., et al.
Publicado: (1987)

Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization.
por: Matthews, N., et al.
Publicado: (1980)

Tumour necrosis factor signalling in health and disease
por: Holbrook, Jonathan, et al.
Publicado: (2019)

Isolation and characterisation of Kasumi-1 human myeloid leukaemia cell line resistant to tumour necrosis factor alpha-induced apoptosis.
por: Ido, M., et al.
Publicado: (1996)

Production of lipopolysaccharide-induced tumour necrosis factor during influenza virus infection in mice coincides with viral replication and respiratory oxidative burst
por: Masihi, K. N., et al.
Publicado: (1995)

Differentiation in the Rodent Ulcer Group of Tumours
por: Lennox, B., et al.
Publicado: (1951)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
por: Shah, P., et al.
Publicado: (1989)

Changes in Eicosanoid and Tumour Necrosis Factor-α Production by Rat Peritoneal Macrophages During Carrageenin-Induced Peritonitis
por: Pruimboom, W. M., et al.
Publicado: (1994)

Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast.
por: Pusztai, L., et al.
Publicado: (1994)

Role of prostaglandins in tumour necrosis factor induced weight loss.
por: Mahony, S. M., et al.
Publicado: (1989)

Tumour necrosis factor: a cytokine with multiple biological activities.
por: Semenzato, G.
Publicado: (1990)

Metabolic effects of tumour necrosis factor alpha in NMRI mice.
por: Mahony, S. M., et al.
Publicado: (1990)

Caffeine potentiates the lethality of tumour necrosis factor in cancer cells.
por: Belizario, J. E., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_kr8oceeei27e2072shbo4qq0r4